GlassScriptPhysician profile
Kevin Burns
NPI 1750527917
$165,108.60
in general payments reported to CMS, 2019-2025
8 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Blood Banking & Transfusion Medicine provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $96.99 · 2021: $80K · 2022: $77K · 2023: $7,313 · 2024: $81.05 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,000 · Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,000.00 |
| Food and Beverage | $1,011.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vitalant | $164,000.00 | 2021-2023 | |
| Stryker Corporation | $453.74 | 2025 | Flowtriever, Flowstasis, Clottriever Bold Catheter |
| Histosonics, INC. | $200.92 | 2024-2025 | |
| Nuvasive, INC. | $162.67 | 2023 | Xlif |
| Angiodynamics, INC. | $150.75 | 2023 | Nanoknife |
| Boston Scientific Corporation | $96.99 | 2019 | |
| Ibsa Pharma INC. | $24.46 | 2025 | Tirosint, Licart, Flector |
| Inari Medical, INC. | $19.07 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Burns listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.